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Abstract 
In the present work we studied the relationship between the phosphorylated 150- and 160-kDa proteins and other SR proteins in the 
150 000-170 00 range of molecular masses, on SDS-PAGE, the identification of their kinase, as well as the purification and structural 
interactions between these proteins and the ryanodine receptor (RyR). The phosphorylated 150-kDa protein was identified as 
sarcalumenin based on: (a) its cross-reactivity with three different monoclonal antibodies specific for sarcalumenin, (b) its mobility in 
SDS-PAGE which was modified upon digestion with endoglycosidase H, (c) its elution from lentiMectin column by c~-methyl mannoside, 
(d) its resistance to trypsin, (e) its ability to bind Ca 2+ and to stain blue with Stains-All. The phosphorylated 160-kDa protein was 
identified as the histidine-rich Ca 2+ binding protein (HCP) based on: (a) its Ca2+-binding property and staining blue with Stains-All, (b) 
phosphorylation with the catalytic subunit of cAMP-dependent kinase, (c) its increased mobility in SDS-PAGE in the presence of Ca 2+, 
(d) its heat stability and (e) its partial amino acid sequence. The endogenous kinase was identified as casein kinase II (CK II) based on the 
inhibition of the endogenous phosphorylation 160/150-kDa proteins by heparin, 5,6-dichlorobenzimidazole riboside, polyaspartyl peptide 
and hemin, and its ability to use [',/-32p]GTP as the phosphate donor. The association of CK II with SR membranes, was demonstrated 
using specific polyclonal anti-CK II antibodies. The luminal ocation of CK II is suggested because CK II was extracted from the SR by 1 
M NaC1 only after their treatment with hypotonic medium, and CK II activity was inhibited with the charged inhibitors heparin and 
polyaspartyl peptide only after their incubation with the SR in the presence of NP-40. The 160- and 150-kDa proteins were purified on 
spermine-agarose column, and were phosphorylated byCK II. Like the endogenous phosphorylation f the 150/160-kDa proteins in SR, 
the phosphorylation f the purified proteins by CK II was inhibited by La 3+ (CI50 = 4 txM) and hemin. The results suggest he 
phosphorylation f the luminally located sarcalumenin and HCP with CK II. 
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1. Introduction 
One major hypothesis for excitation-contraction (E-C) 
coupling suggests that a voltage sensor molecule on trans- 
Abbreviations: EGTA, ethylene glycol bis([3-aminoethyl ether)- 
N.N,N',N'-tetraacetic acid; Tricine, N-[2-hydroxy-l,l-bis(hydroxy- 
methyl)ethyl]glycine; Mops, 3-(N-morpholino)propanesulfonic acid; 
SDS-PAGE, sodium dodecyl sulfate polyacrylamide g l electrophoresis; 
SR, sarcoplasmic reticulum; HSR, heavy SR; CHAPS, 3-[(3-cholami- 
dopropyl)dimethylammonio]-l-propanesulfonate; PMSF, phenylmethyl- 
sulfonyl fluoride; RyR, ryanodine r ceptor; ATPase, CaZ+-ATPase; HCP, 
histidine-rich Ca2+-binding protein; CK, casein kinase. 
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verse tubules undergoes conformational changes in re- 
sponse to depolarization. These changes may be transmit- 
ted to the ryanodine receptor (RyR)/CaZ+-release channel 
on the junctional face of the sarcoplasmic reticulum (SR) 
[1,2]. The voltage sensor is now believed to be the 
dihydropyridine receptor [2,3] where, conformational 
changes in it may modulate the opening of the SR Ca2+-re - 
lease channel. Recently, the involvement of several other 
proteins in the regulation/modulation of the SR Ca2+-re - 
lease channel has been suggested [4-11]. It has been 
shown that a 95-kDa protein, an intrinsic protein of the 
junctional SR, interacts with both the DHP receptor and 
the RyR [4]. Electron microscopy [5], as well as biochemi- 
cal studies [6-9], suggest hat calsequestrin is linked with 
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the junctional face membrane where the Ca2+-release 
channel is localized, and that it plays an important role in 
Ca z+ release. Recently, the modification of RyR/Ca2+-re - 
lease channel behavior by the tightly associated FK-506 
binding protein has been demonstrated [ 10,11 ]. 
Several SR proteins in the 150-170kDa range on SDS- 
PAGE were characterized, and their involvement in the 
regulation of Ca 2÷ transport was suggested [12-21]: (1) A 
160-kDa Ca 2÷ binding glycoprotein was purified, charac- 
terized, cloned, sequenced, located in the SR lumen and 
named sarcalumenin [12-14]. (2) A 170-kDa protein was 
labeled with [14C]doxorubicin and suggested to be an 
integral part of the ryanodine receptor [15]. (3) A 170-kDa 
protein was eluted from reactive-red agarose column by 
caffeine and suggested to be the caffeine-receptor [16]. (4) 
A 165-kDa protein that binds Ca 2÷ and low-density 
lipoprotein, referred to as histidine-rich Ca 2 ÷ binding pro- 
tein (HCP), was purified and cloned [17,18]. It has been 
shown to bind tightly to junctional membrane and to be 
phosphorylated by cyclic AMP-dependent protein kinase 
[19]. (5) A 170-kDa Stains-All blue protein was shown to 
interact specifically on affinity column with a 95-kDa 
integral protein of junctional SR [5]. This protein, how- 
ever, was suggested to be identical to HCP [19]. The 
function of these proteins is unknown. In our previous 
studies [20,21], we demonstrated the phosphorylation of
150- and 160-kDa proteins by an endogenous phosphoryla- 
tion system. This work has been extended in the accompa- 
nying paper [22], where we show that phosphorylation f
the 150- and/or 160-kDa proteins inhibits ryanodine bind- 
ing due to alterations in the Ca 2÷- and ryanodine-binding 
affinities of the RyR. 
In the present study, we identified the phosphorylated 
150- and 160-kDa proteins as sarcalumenin and HCP as 
well as their kinase as casein kinase II. 
2. Experimental procedures 
2.1. Materials 
Lentil-lectin Sepharose 4B, a-methyl mannoside, 
polyaspartate, 5 6-dichlorobenzimidazole riboside, hemin, 
heparin, trypsin (type III), endoglycosidase H 
(Streptomyces griseus), dithiothreitol, sodium deoxy- 
cholate, CHAPS, spermine, spermine-agarose and alkaline 
phosphatase-conjugated goat anti-mouse IgG were ob- 
tained from Sigma. Sephadex G-50 (fine) was obtained 
from Pharmacia. Casein kinase II was purchased from 
Boehringer. Other reagents were as in the accompanying 
paper [22]. 
2.2. Membrane preparations 
SR membranes were prepared from rabbit fast-twitch 
skeletal muscle as described by Saito et al. [23], Lai et al. 
[24] or MacLennan [25]. In all these SR preparations, the 
proteinase inhibitors, PMSF (0.2 mM), benzamidine (0.8 
mM), and leupeptin (0.5 I~g/ml), were included in all 
solutions. SR was suspended in a buffer containing 0.2 M 
sucrose and 10 mM Tricine, pH 8.0, and stored at -70°C. 
Protein concentration was determined by the method of 
Lowry et al. [26]. 
2.3. Protein phosphorylation, gel electrophoresis, auto- 
radiography and [3H]ryanodine binding 
These assays were carried out as described in the 
accompanying paper [22], or in the figure or table legends. 
2.4. Immunoblotting 
Western blot analysis was carried out as described 
previously [27]. The separated proteins from SDS-PAGE 
were electrophoretically transferred onto nitrocellulose 
membranes. The membranes were blocked with 5% nonfat 
dry milk and 0.1% Tween-20 in Tris-buffered saline, 
incubated with the antibodies (1:1000), then with alkaline 
phosphatase conjugated to anti-mouse IgG antibody or to 
protein A as secondary antibody. The color was then 
developed (up to 5 min) with 5-bromo-4-chloro-3-indolyl 
phosphate and Nitro blue tetrazolium. 
2.5. Purification of 150-kDa (sarcalumenin), 160-kDa 
(HCP) and 53-kDa glycoprotein 
The 150-kDa, 160-kDa and 53-kDa proteins were par- 
tially purified by a new one-step method using spermine- 
agarose column. HSR [24], R 4 or R 3 [23] membranes (30 
to 100 mg) were sedimented at 100000 × g for 30 min 
and resuspended at a final protein concentration of 5 
mg/ml in a solution containing l0 mM Tris-HC1, pH 8.5, 
0.1 mM PMSF, 0.5 Izg/ml leupeptin, and 1 mM EGTA. 
The vesicles were slowly stirred at 4°C for 30 min, and 
then centrifuged at 100000 X g for 30 min at 4°C. The 
supernatant (EGTA extract) was collected, and NaC1 and 
CaC12 (from 4 M and 0.1 M stock solutions, respectively) 
were added to the final concentration of 0.12 M and 0.8 
raM, respectively. This extract was loaded onto a sper- 
mine-agarose column (1.0/2.7 cm) pre-equilibrated with 
l0 mM Tris-HC1, pH 8.5, 0.12 M NaC1, and 0.1 mM 
PMSF (buffer A). The column was washed with 20 ml 
cold (~ 8°C) buffer A, which elutes the 53-kDa glyco- 
protein. Sarcalumenin with other proteins was eluted with 
buffer A containing 5 mM of spermine. By increasing 
NaC1 concentration to 0.3 M, sarcalumenin was eluted. 
The 160-kDa protein was eluted from the column by 1.0 M 
NaC1. The rate of loading and washing was about 1 ml/3 
min. Fractions (0.6 ml) were collected and 40-1~1 samples 
were subjected to SDS-PAGE followed by Coomassie 
staining or electroblotting [27]. The purified proteins were 
stored at - 20°C. 
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Fig. 1. Elution profiles of phosphorylated 150-kDa protein and sarcalumenin from lentil-lectin column. HSR membranes (6 mg) were phosphorylated with 
[~_32 P]ATP as described under Section 2, solubilized with deoxycholate (1 mg/mg protein) in the presence of 100 mM NaF, 0.8 mM benzamidine, and 
0.2 mM PMSF. After 20 min at ice, the deoxycholate extract was centrifuged at 40000 × g for 20 min. The free [~/-32p]ATP in the supernatant was 
separated from the proteins using the Sephadex G-50 chromatography-centrifugation method [44]. The eluent was applied (1 ml/10 min) three times to a 
lentil-lectin-Sepharose column (1.2 x 5 cm) pre-equilibrated with a solution containing: 20 mM Tris, pH 7.5, 100 mM NaF, 0.1% deoxycholate, and 0.2 
mM PMSF (buffer-L). The loaded column was washed with buffer-L and the glycoproteins were eluted with buffer-L containing 0.5 M of a-methyl 
mannoside (aMM). SDS-PAGE profile of the fractions applied and eluted from the lentil-lectin column is shown in (A), the corresponding autoradiogram 
in (B), and the immunoblot staining using monoclonal antibodies ((XIIC 4) against he sarcalumenin (1:1000)), and alkaline phosphatase-conjugated 
anti-mouse IgG antibodies as secondary antibodies i presented in (C). SDS-PAGE and immunoblot staining were carried out as described in Section 2. D 
indicates deoxycholate extract and E indicates void fraction. 
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Fig. 2. Effect of Endo-H and trypsin treatment on the phosphorylated 160/150-kDa proteins and their Ca2+-binding capability. HSR membranes were 
phosphorylated for 1 min with 0.4 mM of [~-32p]ATP in the presence of 60 mM NaF, and then treated with either Endo-H or trypsin. For Endo-H 
treatment (A), the phosphorylated membranes (1 mg/ml) were incubated with 0.7% C u E 9 and boiled for 3 min, and then leupeptin (0.5 I~g/ml) and 
Endo-H (0.04 unit/ml) were added. The samples were then incubated for 2 h at 37°C and run on SDS-PAGE (5-9% acrylamide) according to Ref. [45]. 
The gel was either stained with Coomassie or transferred onto nitrocellulose membranes and immunostained with monoclonal antibodies (XIIC4). The 
arrow heads point to the new band formed by Endo-H treatment. For trypsin treatment (B), the phosphorylated membranes were treated with trypsin 
(trypsin/SR mass ratio of 1:50) for 2 min. The treated membranes were subjected to SDS-PAGE (6% acrylamide) and autoradiography, as described in 
Section 2. 45Ca2+ ligand overlay of nitrocellulose blot (C) was carried out as described previously [46]. (a) is the autoradiogram of the 45Ca2+ overlay 
blot, and (b) is the immunoblot. 
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3. Results 
3.1. Is the phosphorylated 160- or 150-kDa protein sar- 
calumenin ? 
The relationship between the SR proteins in the molecu- 
lar weight range of 150000-170000 [12-20] and the 
phosporylated 150- and 160-kDa proteins is studied using 
several approaches uch as: protein purification, ligand 
binding and specific antibody interaction. Fig. 1 shows the 
purification of the 150-kDa glycoprotein (sarcalumenin) 
from the deoxycholate extract of [',/-3Ep]ATP phosphory- 
lated membranes, using lentil-lectin affinity chromatogra- 
phy [13]. The SDS-PAGE protein profile, the correspond- 
ing autoradiogram and immunoblot of the various fractions 
from the column are illustrated. The unbound or weakly- 
bound proteins that include part of the phosphorylated 
150/160-kDa proteins are washed off the column and 
then, as reported previously [13], a-methyl mannoside 
(aMM)  elutes three major proteins with molecular masses 
of 150, 95 and 53 kDa. Among these three proteins, the 
150-kDa protein is the only phosphorylated protein (Fig. 
1B). The phosphorylated 150-kDa protein, eluted by a MM 
was identified as sarcalumenin by using monoclonal anti- 
bodies (XIIC 4) directed against a common domain of the 
53-kDa glycoprotein and sarcalumenin (kindly provided by 
K.P. Campbell, Iowa University). Similar results were 
obtained with monoclonal antibodies G 7 and G10 (kindly 
provided by Prof. D.H. MacLennan, University of 
Toronto). It should be noted that although the deoxy- 
cholate extract of the HSR was passed through the column 
three times, only parts of the glycoproteins were bound to 
the column. This led us to develop a new method for its 
purification (see Fig. 5). 
To ensure that the phosphorylated 150-kDa is the 160- 
kDa glycoprotein known as sarcalumenin, we carried out 
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Fig. 3. Identification ofthe phosphorylated 160-kDa protein as HCP. In A, SR membranes were phosphorylated with 0.3 mM [~/-32 P]ATP in the presence 
of 60 mM NaF, subjected toSDS-PAGE, staining and destaining as described inSection 2. The phosphorylated 160- and 150-kDa protein bands were cut 
off the gel and run in a second gel (5% acrylamide s parating gel and 3% stacking el) containing 0.1 mM EGTA or 1 mM CaC12. In each gel the original 
phosphorylated membranes (applied to the first gel) are also shown. 150-kDa nd 160-kDa proteins were purified and phosphorylated with CK II as 
described in Figs. 5 and 6, respectively and then subjected to electrophoresis in gels containing either 1 mM CaC12 or 0.1 mM EGTA. In B, the heat 
stability of the phosphorylated 160-kDa protein is demonstrated. SR membranes, i olated according to MacLennan [25], were phosphorylated as in A. 
Then, Triton X-100 was added to aliquots to a final concentration f 1% and the samples were incubated for 15 rain at boiled water followed by 
centrifugation for 10 min at 16 800 × g. The obtained supernatant was subjected toSDS-PAGE, staining, destaining and to autoradiography as described in
Section 2. 
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several other experiments. The effect of the endoglycosi- 
dase H, which digests the carbohydrate chains in the 
glycoprotein (sarcalumenin) and increases its mobility in 
SDS-PAGE, on the phosphorylated 150-kDa protein is 
shown in Fig. 2A. Parallel to a decrease in the 150-kDa 
phosphorylated band, a new phosphorylated band with a 
higher mobility appeared. This new protein band cross-re- 
acts with monoclonal antibodies against sarcalumenin 
(XIIC4), as does the phosphorylated 150-kDa. As shown 
for sarcalumenin [12], the phosphorylated 150-kDa protein 
in intact SR membranes i  resistant to trypsin (Fig. 2B). It 
seems, however, that at least part of the 160-kDa is 
digested by trypsin. The phosphorylated protein that 
cross-reacted with antibody against sarcalumenin also binds 
45Ca2 + (Fig. 2C) and stained blue with Stains-All (data not 
shown). 
3.2. Identification of the 160-kDa protein as HCP 
Since the phosphorylated 160-kDa protein stained blue 
with Stains-All (not shown) and binds Ca 2÷ (Fig. 2B), it is 
possible that it is the HCP. To test this possibility we 
carried out the following experiments. Fig. 3A shows that, 
as it has been shown previously for HCP [19], the phos- 
phorylated 160-kDa protein exhibited a Ca2+-induced shift 
in its electrophoretic mobility. The Ca2+-induced shift in 
the mobility of 160-kDa protein was demonstrated on the 
SR phosphorylated 150- and 160-kDa proteins and on 
purified 160- and 150-kDa proteins (see Fig. 5) phosphory- 
lated by added casein kinase II (see Fig. 6). The phospho- 
rylated bands were cut off the gel and subjected to a 
second electrophoresis in the presence of EGTA or Ca 2÷. 
In either case, Ca 2÷ induced a significant shift in the 
A CK-II Inhibitors 
CBB Heroin , paM 
0 100 200 
Heparin , pg/ml Polyaspartate,  tIM 
0 25 50 0 150250 
~iii!i!!ii~!i!i!!i~i!i!iii!!!U~!~i!!~! 
B 
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[T -32P]GTP  
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mM 
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lS0kDa~ 
ATPase - 
~,~, ATPase  -
C CK-II Antibodies 
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RyR ~_. ~ --'-- 
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Fig. 4. Endogenous phosphorylation f 160/150-kDa proteins is carried out by casein kinase II. In A, SR membranes were phosphorylated with 0.2 mM 
[~/_ 32 P]ATP in the presence of 60 mM NaF and the indicated hemin, heparin or polyaspartate concentrations. Heparin and polyaspartate were incubated for 
10 min at 30°C with the SR in the presence of 0.03% NP-40 prior to the phosphorylation reaction. In B, SR membranes were phosphorylated with 0.3 mM 
[~/-32p]GTP in the presence of the indicated NaF concentrations, as described in Fig. 1. In C, different SR preparations R 3 [23] and HSR [24] and SR 
sub-fractions were analyzed by SDS-PAGE, and either stained with Coomassie or electroblotted and immunostained with polyclonal antibodies against CK 
II (15% acrylamide) (provided by Dr. Issinger) as described in Fig. IC, except hat alkaline phosphatase-conjugated protein A was used as the secondary 
antibody. The arrows indicate the cross-reactive band (45-kDa). 
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mobility of 160-kDa but not in 150-kDa, supporting the 
identification of 160-kDa as HCP. It has been shown 
previously that HCP is stable to boiling [19]. Fig. 3B 
shows that boiling of phosphorylated SR membranes re- 
sulted in soluble phosphorylated 160-kDa protein. 
We also carried out amino acid sequence of the phos- 
phorylated 160-kDa protein as described previously [28,29]. 
The phosphorylated membranes were subjected to SDS- 
PAGE and then electroblotted onto PVDF membranes that 
were subjected to in situ trypsin digestion. The resulting 
peptide fragments were separated by reverse phase HPLC. 
The phosphopeptide-containing peakwas applied to a gause 
phase sequenator and the following sequence was ob- 
tained: Ala-Leu-Ala-Asp-Met-Leu-Glu-Thr-Pro. This se- 
quence is identical to the C-terminal of the HCP sequence 
as deduced from the cDNA (positions 842-850). Interest- 
ingly, the same tryptic fragment was obtained and se- 
quenced from the purified HCP [20]. 
3.3. Identification of the endogenous kinase as casein 
kinase II 
Screening of the sarcalumenin and HCP amino acid 
sequence for consensus phosphorylation sites [30], using 
the prosite subroutine (GCE program), revealed 30 and 26 
sites for casein kinase II (CK II), 9 and 15 for protein 
kinase C, none for either calmodulin-dependent or cAMP- 
dependent protein kinases for sarcalumenin and HCP, re- 
spectively. The involvement of CK II in the endogenous 
phosphorylation of 160/150-kDa proteins was demon- 
A 
"~ 0.3M NaC! 1M NaCl 
~ 1 3 5 38 39 40 41 42 44 46 50 62 66 67 68 69 70 
160kDa- 
150kDa-- 
53kDa - . . . . . . . . .  
iiiiiiii~ ¸ ~ iiiii~? : 
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Fig. 5. A simple, one-step method for purification of sarcalumenin, HCP and the 53-kDa glycoprotein, using a spermine-agarose column. In A, EGTA 
extract of HSR was obtained, and HCP, sarcalumenin a d 53-kDa glycoproteins were obtained as described in Section 2. The EGTA extract (lane 1), the 
void fraction of the spermine-agarose column (lane 2), the washed fractions (fractions 1,3,5, 53-kDa), and the proteins eluted with NaC1; 0.3 M (fractions 
38-62, 150-kDa) or 1 M (fractions 66-70,160-kDa) were subjected to SDS-PAGE (7% acrylamide). In B, samples from another purification were 
subjected to SDS-PAGE (7% acrylamide) and the gets were either stained with Coomassie blue or electroblotted to nitrocellulose membrane and 
immunostained with anti-53-kDa glycoprotein monoclonal ntibodies Gi0. The indicated samples are as in A, except fractions 23 and 24 that are fractions 
eluted from the column with 0.12 M NaCI + 8 mM spermine. Sarca indicates sarcalumenin. 
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strated by the effects of hemin, polyaspartate and heparin, 
inhibitors of CK II [31,32], on their phosphorylation. Hemin 
inhibited the endogenous phosphorylation f 160/150-kDa 
proteins (Fig. 4A). Heparin and polyaspartate were found 
to inhibit the HCP and sarcalumenin phosphorylation ly 
when incubated with the SR in the presence of relatively 
low concentrations of detergent such as NP-40 (Fig. 4A). 
In the absence of NP-40 no significant inhibition of the 
phosphorylation of 160-/150-kDa proteins was obtained 
with heparin (up to 100 ~M) and about 30% inhibition 
was obtained with 250 txM polyaspartate. The non-charged 
compound 5,6-dichlorobenzimidate riboside inhibited the 
phosphorylation i the absence of NP-40 (not shown). 
These results may indicate on the luminal location of the 
CK II. 
Another unique character of CK II is that it utilizes 
GTP as the phosphate donor almost as effectively as ATP 
[31 ]. Fig. 4B shows that the endogenous kinase phosphory- 
lates these proteins using [y-32p]GTP. Therefore, these 
results strongly suggest that the endogenous kinase respon- 
sible for the phosphorylation f 160/150-kDa protein is of 
a CK II type. [y-32p]GTP labeled the Ca2+-ATPase, a
labeling which was not observed under the same condi- 
tions with [y-32p]ATP. This labeling may represent the 
phosphorylated nzyme (E-P) that remains table under the 
electrophoresis conditions. 
The presence of CK II in different SR preparations i
demonstrated in Fig. 4C by using specific antibodies against 
CK II (kindly provided by Dr. Issinger, Hamburg). More- 
over, CK II remains associated with the SR membranes 
after their EGTA-extraction which releases luminal and 
peripheral proteins. CK II was extracted from the EGTA- 
treated SR membranes by their extraction with 0.5 to 1 M 
NaC1 (data not shown). 
3.4. Purification of sarcalumenin and HCP 
To demonstrate direct phosphorylation f sarcalumenin 
and the HCP by CK II, we purified both proteins from the 
EGTA extract of SR membranes. Sarcalumenin was previ- 
ously purified using sequential column chromatography on 
DEAE-Sephadex and lentil-lectin Sepharose 4B column 
[ 13]. HCP was also purified from SR by heat treatment and 
chromatography on Mono-Q column [17]. Here we devel- 
oped a simple and rapid method for purification of these 
proteins and of the 53-kDa glycoprotein in one-step and 
with higher yield, using chromatography on spermine- 
agarose column. Sarcalumenin, HCP and the 53-kDa 
glycoprotein were isolated from the EGTA extract using 
the method described in Section 2, and the results are 
presented in Fig. 5. On the spermine-agarose column, 
under the ionic strength and pH used (0.12 M NaC1, pH 
8.5), the 53-kDa glycoprotein did not bind, and it was 
effectively washed off with 0.12 M NaC1. Addition of 5 
mM spermine to the washing buffer elutes several proteins 
with apparent molecular masses of about 150000 (sarca- 
lumenin), 190000, 85 000, and 53 000 (glycoprotein). Sar- 
calumenin was eluted with 0.3 M NaC1 or with 0.12 M 
NaC1 + 8 mM spermine and HCP with 1.0 M NaC1. Both 
purified sarcalumenin and HCP were stained blue with 
Stains-All (not shown). The immunoblot of fractions ob- 
tained from another purification (Fig. 5B), shows the 
separation between the two glycoproteins, 53-kDa and 
sarcalumenin. 
3.5. Phosphorylation of the purified sarcalumenin and 
HCP by CK n 
Our results suggest that the 150-kDa and 160-kDa 
proteins, identified as sarcalumenin and HCP, respectively, 
are phosphorylated by the same kinase type, most probably 
CK II (Fig. 4). Thus, we expect he purified proteins to be 
phosphorylated by CK II. CK II but not the catalytic 
subunit of the cAMP-dependent kinase, stimulated the 
phosphorylation f the purified sarcalumenin (Fig. 6A). 
The maximal phosphate incorporated into the purified 
sarcalumenin (6 to 8 mol/mol) is about 20% higher than 
in the SR protein. Also, phosphopeptide maps of the 
purified and the SR proteins indicate the presence of 
several identical and a few non-identical phosphopeptides. 
Protein kinase C slightly stimulated the phosphorylation 
of sarcalumenin (data not shown). HCP is phosphorylated 
by both CK II and by the catalytic subunit of cAMP-de- 
pendent kinase (Fig. 6). Interestingly, although no consen- 
sus phosphorylation sites for PK-A were found in HCP, 
the protein was phosphorylated by PK-A, as also reported 
previously [19]. 
La 3 + inhibited the phosphorylation f the purified sar- 
calumenin and HCP by CK II, with half-maximal inhibi- 
tion obtained at about 4 IxM of La 3+ (Fig. 6B), similar to 
the SR-associated proteins (Ref. [20] and Fig. 6B). Hemin 
(Fig. 6B) as well as heparin and polyaspartate (data not 
shown) inhibited the phosphorylation f the purified sar- 
calumenin. No protein phosphorylation was obtained in the 
absence of CK II (data not shown). 
3.6. The distribution of sarcalumenin and HCP in SR 
sub fractions 
The distribution of RyR, HCP and sarcalumenin in 
different SR preparations and SR subfractions i presented 
in Fig. 7 and Table 1. As expected, RyR is enriched in the 
heavy fractions of the SR (HSR) (Fig. 7A, Table l, 
compare HSR, R 4 to R 1, R 2 and light SR (LSR)). The 
distribution of sarcalumenin, as followed by Stains-All, 
phosphorylation and immunoblot staining, indicates that 
this protein is present in light, intermediate (R 2 and R 3) 
and heavy SR (R4), although it is enriched in the light SR, 
R 2 and in SR isolated according to MacLennan [25] (Fig. 
7B and Table 1). The 53-kDa glycoprotein distribution is 
similar to that of sarcalumenin. The heavy fractions of SR 
are enriched with both RyR and HCP (Table 1), in agree- 
ment with previous findings [19]. 
96 V. Shoshan-Barmatz et al. / Biochimica et Biophysica Acta 1283 (1996) 89-100 
The sarcalumenin and HCP phosphorylation system 
(which represents he phosphatase(s) and kinase(s) activi- 
ties) is present in all SR preparations i olated according to 
Saito et al. [23], Lai et al. [24], and MacLennan [25] (Table 
1). 
ent while RyR at the bottom of the gradient (not shown). 
These results suggest that, under the SR solubilization and 
separation conditions used, the phosphorylated sarcalu- 
menin is not tightly associated with the RyR. 
3.7. The structural interaction between ryanodine receptor 
and sarcalumenin 
In the accompanying paper [22], we show that the level 
of 32p incorporation i to 150/160-kDa proteins affects the 
binding of ryanodine to RyR, suggesting an interaction 
between these proteins. The inhibitory effect of sarcalu- 
menin and HCP phosphorylation  ryanodine binding is 
reversed in the presence of relatively low concentrations of 
CHAPS (Table 2). This effect of CHAPS is due to alter- 
ation of the ryanodine binding affinity (K D) (Fig. 8). The 
phosphorylation decreases the total binding sites (Bma x) by 
about 90% (from 12.1 _ 2.8 pmol/mg, n = 3 to 1.0 + 0.4 
pmol/mg, n = 3) and the K D by 1.5-fold (from 11.3 + 2 
nM, n=3 to 16.4___2 nM, n=3) .  Addition of 0.1% 
CHAPS to control membranes increased K o for ryanodine 
binding by 3.1-fold (from 3.5 +0.3 nM, n= 3 to 11.2 + 
0.7 nM, n = 3) with no significant effect on the Bma x 
value (from 11.8+__0.7 pmol/mg, n=3 to 12.9_2.4 
pmol/mg, n = 3). Thus, addition of CHAPS to the phos- 
phorylated membranes resulted in 3.2-fold lower affinity 
compared to that of control membranes, uggesting modifi- 
cation of the phosphorylation effect on ryanodine binding 
by CHAPS. 
To test the interaction between the ryanodine receptor 
and sarcalumenin, we purified the RyR (from the CHAPS 
extract) both by chromatography on spermine-agarose col- 
umn [33], and density gradient centrifugation [24]. Using 
the spermine-agarose column, a phosphorylated 150-kDa 
protein which cross-reacted with monoclonal antibodies 
(XIIC 4) against sarcalumenin s co-purified with the RyR 
(not shown). However, using sucrose-gradient centrifuga- 
tion [24], the phosphorylated sarcalumenin (identified with 
XIIC 4 antibodies) is distributed at the middle of the gradi- 
4. Discussion 
In our accompanying paper [22], we have shown that 
phosphorylation f 160/150-kDa proteins resulted in alter- 
ation of the properties of the RyR as reflected in changes 
in Ca 2+- and ryanodine-binding affinities. In this paper we 
have identified the 160- and 150-kDa phosphorylated pro- 
teins, their kinase, and provided some data on the interac- 
tion of these proteins with the RyR. 
4.1. The identity of the 160/150-kDa proteins as sarcalu- 
menin and HCP 
The phosphorylated 150-kDa protein is identified as 
sarcalumenin based on the following: The 150-kDa phos- 
phorylated protein was eluted from the lentil-lectin column 
by a-methyl mannoside (Fig. 1), and its mobility was 
modified by treatment with Endo-H (Fig. 2A), suggesting 
that it is a glycoprotein. This protein cross-reacted with 
monoclonal antibodies, Gl0, G 7 and XIIC 4, specific for 
the sarcalumenin and the 53-kDa glycoproteins. It stained 
blue with Stains-All, bound Ca 2+ and was resistant o 
trypsin (Fig. 2). These results are in agreement with the 
reported sarcalumenin properties. 
The identification of the phosphorylated 150-kDa pro- 
tein as sarcalumenin and its phosphorylation by CK II 
(Fig. 6) allow us to reach a conclusion about the possible 
location of phosphorylation site(s). The 53-kDa glyco- 
protein sequence is included in the sarcalumenin sequence 
[14], but is not phosphorylated ither in the SR by the 
endogenous kinase or as purified protein by CK II. This 
suggests that the phosphorylation site(s) is not located in 
the common sequence (amino acid residues 437 to the 
carboxyl terminus). This leaves the location of the phos- 
Table l 
Distribution of 150- and 160-kDa proteins and RyR in different SR preparations 
SR preparations Bound [3 H]ryanodine 
(pmol/mg) 
Phosphorylated proteins (relative units) Proteins amount(relative units) 
150-kDa 160-kDa 150-kDa 160-kDa RyR 
HSR (Saito et al., [23]) 2.7 0.37 0.36 0.42 0.3 0.31 
Fractions from HSR: 
R I 1.2 0.49 0.32 0.57 nd 0.06 
R 2 4.9 0.65 0.49 0.69 0.37 0.46 
R 3 9.1 0.44 0.63 0.60 0.76 0.74 
R 4 13.5 0.39 0.61 0.54 0.75 1.00 
HSR (Lai et al., [24]) 8.3 1.00 0.92 1.00 1.00 0.73 
SR (MacLennan, [25]) 5.6 0.98 0.99 0.73 0.46 0.62 
The different SR preparations were prepared and phosphorylated with the endogenously present kinase in the presence of 0.3 mM [ ~/-32 P]ATP, and 60 mM 
NaF, as described in Section 2. Ryanodine binding was assayed for 20 rain. Quantitative analysis of the protein bands was performed by densitometric 
scanning of the Coomassie stained gel (for RyR) or Stains-All stained gel (for 160- and 150-kDa proteins), as described in Section 2. The results are the 
average of 2-4 experiments which differ by 5 to 15%. n.d. = not determined. 
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phorylation site(s) in one or more of  the 12 possible sites 
for CK II (1 -436  amido acids). The exact location of  the 
phosphorylation site(s) in sarcalumenin will be determined 
in the future by sequencing the isolated phosphorylated 
peptide(s). 
The identity of  the phosphorylated 160-kDa protein as 
the histidine-rich CaR +-binding protein (HCP) [19] is based 
on the partial amino acid sequence of  the phosphorylated 
160-kDa protein, on its staining with Stains-All, its ability 
A 
Coomassie Staining Autorad iogram 
A. Coomassie Staining 
CSR R 1 R 2 R 3 R 4 R 4 LSR Mac HSR 
RyR w -~ ~ ~ ~- - -  
ATPase  
CS 
150- 160- 
HSR kDa kDa 
RyR -- 
160kDa~ ~ ~ 
lS0kDa ~ 
ATPas¢-  ~ 
cs -O  ~ 
150kD 160kD 
Kinases: CKII PICA CKll PKA 
m w l  
B. Immunoblot 
CSR R 1 R 2 R 3 
Sarca 
R 4 R 4 LSR Mac HSR 
B 
Pur i f ied  Sarca lumenin  SR  
Heroin La 3 + 
CBB ~tM: 0 100 Ix.M: 0 1 2 5 10 0 5 
w 
Fig. 6. Phosphorylation f sarcalumenin and HCP by casein kinase II, and 
cAMP-dependent protein kinase. In (A), the purified sarcalumenin or 
HCP were phosphorylated in the absence or in the presence of the 
catalytic subunit of cAMP-dependent kinase (2 p,g) or casein kinase II 
(CK II) (0.05 unit). For CK II, the standard reaction mixture contained 5
mM MgC12, 100 IxM [~/-32p]ATP (0.5 IzCi/nmol), 20 mM Tris-HCl, pH 
7.1, 130 mM NaCI, 2 mM DTr, and also the indicated compounds. For 
cAMP-dependent phosphorylation the reaction mixture contained 25 mM 
Tris-HCl, pH 7.5, 2.5 mM MgCI 2, and 1 mM DTI?. The reaction was 
initiated by the addition of the kinase and was terminated after 15 min of 
incubation at 37°C, by the addition of Laemmli sample buffer. The 
samples were subjected to SDS-PAGE (7% acrylamide) and autoradiog- 
raphy, as described in Section 2. (B) shows the inhibition of the phospho- 
rylation of the purified and SR associated sarcalumenin by La 3+ and of 
purified sarcalumenin by hemin. HSR membranes were phosphorylated in 
the absence and the presence of 5 ~M La 3+ as described in Fig. 2. 
53kDa W ~ a lp  ~ g 
Fig. 7. The distribution of sarcalumenin and the 53-kDa glycoprotein in 
different SR preparations and SR sub-fractions. LSR (light SR), CSR 
(crude SR), R 1, R 2, R 3 and R 4 were obtained as in Ref. [23]. HSR and 
Mac (MacLennan) SR were obtained as described (Refs. [24,25], see also 
Table 1). The different SR preparations and SR sub-fractions (50 p,g) 
were subjected to SDS-PAGE (6% acrylamide), and to immunoblot 
staining as described in Fig. IC. A shows the Coomassie blue staining 
and B the immunoblot staining, using monoclonal antibodies Gl~ ~. 
to bind Ca 2+, and to shift its mobil ity in SDS-PAGE after 
Ca 2 + binding, its heat stability, and its phosphorylation by 
CK  II ( identif ied as the endogenous kinase). Also, as 
expected for HCP [19], this protein is phosphorylated by 
the catalytic subunit of  cAMP-dependent  kinase (Fig. 6). 
The phosphorylation of  HCP by 60-kDa calmodulin-de- 
pendent protein kinase and its possible involvement in the 
modulat ion of  the functional state of the RyR has been 
presented recently [34]. 
4.2. The identity of the endogenous kinase that phosphory- 
lates HCP and sarcalumenin 
The identif ication of  the SR endogenous kinase that 
phosphorylates the sarcalumenin and HCP as a CK  II type 
is strongly supported by the fol lowing: 
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Table 2 
Effect of CHAPS on the inhibition of ryanodine binding by preincubation 
with ATP + NaF 
Preincubation with Incubation Ryanodine 
with CHAPS bound 
(%) pmol /mg 
AdoPPNH]P 
AdoPP[NH]P + NaF 0 4.7 
AdoPP[NH]P + NaF 0.1 7.1 
AdoPP[NH]P + NaF 0.6 7.0 
ATP + NaF 0 1.1 (77) 
ATP + NaF 0.1 7.1 (0) 
ATP +NaF 0.6 5.9 (16) 
HSR membranes (1 mg/ml)  were incubated with 60 mM NaF and 0.4 
mM of AdoPP[NH]P (control) or of ATP. After 2 min at 30°C, aliquots 
were incubated for 5 min at 20°C with the indicated concentration of 
CHAPS in the presence of 0.5 M NaC1, and then assayed for ryanodine 
binding as described previously for soluble RyR [33]. The numbers in 
parentheses indicate % of inhibition. This is a representative experiment 
from four similar experiments. 
teins by the SR endogenous kinase (Fig. 4B), which is 
known to be a phosphate donor unique to CK II [31]. 
(d) CK II is present in different SR preparations and 
subfractions as demonstrated by using specific antibodies 
against CK II (Fig. 4C). This is in accord with the finding 
that 160/150-kDa proteins are phosphorylated by the en- 
dogenous kinase in these fractions (Table 1). Our results 
show that CK II is associated with the SR membranes, and 
it was not extracted by EGTA at alkaline pH, but was 
extracted from these membranes by high NaC1 concentra- 
tion, suggesting its luminal location with its substrate 
sarcalumenin. Furthermore, inhibition of its activity, in the 
SR, by the charged inhibitors, hemin and polyaspartate 
was obtained only in the presence of low concentrations of 
NP-40. These findings are in accord with the observations 
that Golgi complex is permeable to ATP and contains an 
intraluminal CK II which phosphorylates several intralumi- 
hal proteins [35,36]. 
(a) CK II phosphorylates the purified sarcalumenin and 
HCP, and this phosphorylation is inhibited by La 3+ and 
hemin (Fig. 6), similar to their endogenous phosphoryla- 
tion in the SR (Fig. 4 and Ref. [20]). We found that the 
inhibition by La 3 + is not specific to sarcalumenin or HCP 
phosphorylation, but also observed with CK II phosphory- 
lation of purified calsequestrin and casein and of cardiac 
muscle sarcalumenin (data not shown). In Golgi vesicles 
inhibition of luminal casein phosphorylation by La 3 + has 
been previously reported [34]. Thus, we suggest an interac- 
tion of La 3 + with the kinase and inhibition of its activity. 
(b) Inhibitors of CK II inhibited the endogenous phos- 
phorylation of 160/150-kDa proteins (Fig. 4A). 
(c) [~/- 32 P]GTP phosphorylated the 160/150-kDa pro- 
A 
8 10 B 
• , I  6 ° o 
0 ~ 2 ~  0 
5 10 15 20 25 30 35 0 5 10 15 20 25 30 35 
Ryanod ine  , nM Ryanod ine  , nM 
Fig. 8. Effect of CHAPS and phosphorylation of the 150/160-kDa 
proteins on the total ryanodine binding sites and their affinity. HSR 
membranes were incubated for 2 min at 30°C, with 0.4 mM ATP or 
AdoPP[NH]P and 60 mM NaF and then to aliquots CHAPS was added to 
a final concentration of 0.1%, and the membranes were incubated for 5 
min. [3H]Ryanodine binding to unphosphorylated (incubated with 
AdoPP[NH]P and NaF) (0 )  and phosphorylated membranes (©) (in- 
cubated with ATP and NaF) and then both without (A) or with CHAPS 
(B), as a function of ryauodine concentration was assayed for 60 min in 
the presence of l0 ~M CaC12 as described in Table 2. 
4.3. The distribution and localization of the HCP and 
sarcalumenin i  SR 
HCP and sarcalumenin are present in all structural parts 
of the SR (Table I and Fig. 7). This is in agreement with 
previous observations indicating uniform distribution of 
sarcalumenin and HCP through the SR [14,17,19,37,38]. 
The use of trypsin proteolysis and Endo-H digestion as 
topological probes (Fig. 2), as well as the extraction with 
EGTA at alkaline pH (Fig. 5), support he luminal ocation 
of the 150-kDa phosphorylated protein/sarcalumenin 
[12,14]. Our results are in agreement with HCP enrichment 
in the junctional SR [19]. However, the lumenal location of 
HCP [17] has been questioned, and its localization on the 
external side of the junctional SR has been suggested [19]. 
The phosphorylation f the luminally located sarcalu- 
menin suggests that ATP must cross the SR membrane. 
Our recent results show that ATP is transported to the SR 
lumen by a specific 4,4'-diisothiocyanostilbenedisulfonic 
acid (DIDS)-sensitive transport system [39]. 
4.4. The structural interactions between RyR and sarcalu- 
menin and//or HCP 
The alteration of ryanodine and Ca2÷-binding properties 
of the RyR by sarcalumenin and/or HCP phosphorylation 
(Fig. 8, Table 2 and Ref. [22]) suggests an interaction 
between RyR and these proteins. The reversal of the 
inhibitory effect of sarcalumenin a d HCP phosphorylation 
on ryanodine binding by relatively low concentrations of 
CHAPS (Fig. 8 and Table 2) indicates that this interaction 
is modified by the presence of detergent. The separation 
between the phosphorylated or non-phosphorylated pro- 
teins and RyR by sucrose density centrifugation suggests a 
weak interaction, if at all, between the RyR and these 
proteins. It is possible that the phosphorylation f these 
proteins modulates the RyR properties via protein-protein 
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interaction involving other proteins uch as calsequestrin, 
the 53-kDa glycoprotein, annexin VI and/or triadin. The 
regulation of caa+-release activity by the luminally located 
calsequestrin, and its specific attachment to the RyR by an 
anchoring protein, has been suggested [6,9,40,41]. Annexin 
VI, a CaZ+/phospholipid-binding protein, that is associ- 
ated with the luminal surface of the SR, has been shown to 
modify the gating of the Ca2+-release channel [42]. It is 
possible that sarcalumenin and/or HCP modulates the 
RyR activity by being part of the Ca2+-mobilizing machin- 
ery (movement of Ca 2+ from the non-junctional SR, where 
it is pumped by the Ca2+-ATPase to the Ca2+-release 
channel at the junctional membranes [43]), where its/their 
effect is controlled by their phosphorylation state. Re- 
cently, the phosphorylation f HCP and triadin but not of 
the RyR/Ca 2÷ channel by the membrane-bound 60-kDa 
protein kinase has been demonstrated, and a possible in- 
volvement of these phosphorylated proteins in the modula- 
tion of the functional state of the channel has been pro- 
posed [34]. 
The identification of the HCP and sarcalumenin associ- 
ated protein(s) is important for the elucidation of the 
molecular components of the RyR complex, and for under- 
standing the mechanism by which the RyR is regulated by 
the phosphorylation/dephosphorylation of hese proteins. 
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